Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Study on the Mechanism of QRICH1 Mediating PRMT1 to Regulate the Arginine Methylation Modification of cGAS to Promote Arsenics-Induced Pyroptosis in Hepatocellular Carcinoma Cells. | J Hepatocell Carcinoma | 2025 | 40124968 | PubTator, text mining | PubMed |
| Design, synthesis and evaluation of pyrimidinobenzylamide and pyrimidinothiophenamide derivatives as inhibitors of DOT1L and related epigenetic targets DNMT3a, PRMT4 and other HMTs. | RSC Med Chem | 2025 | 40061000 | PubTator, text mining | PubMed |
| Protein Arginine Methyltransferase 1: A Multi-Purpose Player in the Development of Cancer and Metabolic Disease. | Biomolecules | 2025 | 40001488 | PubTator, text mining | PubMed |
| Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy. | Cell Rep | 2025 | 39977265 | PubTator, text mining | PubMed |
| Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity. | Arterioscler Thromb Vasc Biol | 2025 | 39945068 | PubTator, text mining | PubMed |
| Combined genomics and proteomics unveils elusive variants and vast aetiologic heterogeneity in dystonia. | Brain | 2025 | 39937650 | PubTator, text mining | PubMed |
| Fructose-induced progression of steatohepatitis involves disrupting aldolase B-AMPK signaling in methionine adenosyltransferase 1A deficient mice. | Metabolism | 2025 | 39922455 | PubTator, text mining | PubMed |
| Discovery of novel PRMT1 inhibitors: a combined approach using AI classification model and traditional virtual screening. | Front Chem | 2025 | 39906150 | PubTator, text mining | PubMed |
| Arginine methyltransferase PRMT1 promotes ferroptosis through EGR1/GLS2 axis in sepsis-related acute lung injury. | Commun Biol | 2025 | 39901028 | PubTator, text mining | PubMed |
| TRIM21-mediated PRMT1 degradation attenuates colorectal cancer malignant progression. | Cell Death Dis | 2025 | 39890802 | PubTator, text mining | PubMed |
| PRMT1-methylated MSX1 phase separates to control palate development. | Nat Commun | 2025 | 39843447 | PubTator, text mining | PubMed |
Corrigendum to "The role of PRMT1 in cellular regulation and disease: Insights into biochemical functions and emerging inhibitors for cancer therapy" [European Journal of Pharmaceutical Sciences Volume 204, 1 January 2025, 106958]. | Eur J Pharm Sci | 2025 | 39827078 | PubTator, text mining | PubMed |
| Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy. | Cell Rep | 2025 | 39817908 | PubTator, text mining | PubMed |
| Baicalein attenuates ovalbumin-induced allergic rhinitis through the activation of nuclear receptor subfamily 4 group a member 1. | Immunol Res | 2025 | 39808359 | PubTator, text mining | PubMed |
| PRMT1-Mediated Arginine Methylation Promotes Corneal Epithelial Wound Healing via Epigenetic Regulation of ANXA3. | Invest Ophthalmol Vis Sci | 2025 | 39786757 | PubTator, text mining | PubMed |
| Positive feedback between arginine methylation of YAP and methionine transporter SLC43A2 drives anticancer drug resistance. | Nat Commun | 2025 | 39747898 | PubTator, text mining | PubMed |
| Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer. | Cancer Res Commun | 2025 | 39699269 | PubTator, text mining | PubMed |
| PRMT1-mediated methylation regulates MLL2 stability and gene expression. | Nucleic Acids Res | 2025 | 39698834 | PubTator, text mining | PubMed |
| PRMT1 Promotes the Self-renewal of Leukemia Stem Cells by Regulating Protein Synthesis. | Adv Sci (Weinh) | 2025 | 39668478 | PubTator, text mining | PubMed |
| The role of PRMT1 in cellular regulation and disease: Insights into biochemical functions and emerging inhibitors for cancer therapy. | Eur J Pharm Sci | 2025 | 39521191 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=8